IDEX Co. (NYSE:IEX) Holdings Lowered by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank reduced its position in shares of IDEX Co. (NYSE:IEX - Free Report) by 6.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 116,132 shares of the industrial products company's stock after selling 8,167 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned approximately 0.15% of IDEX worth $25,213,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in IEX. Morgan Stanley grew its position in IDEX by 274.1% during the fourth quarter. Morgan Stanley now owns 2,151,334 shares of the industrial products company's stock worth $491,214,000 after buying an additional 1,576,263 shares during the period. Norges Bank acquired a new position in IDEX during the fourth quarter worth about $226,556,000. Alecta Tjanstepension Omsesidigt grew its position in shares of IDEX by 420.8% in the fourth quarter. Alecta Tjanstepension Omsesidigt now owns 781,172 shares of the industrial products company's stock valued at $169,600,000 after purchasing an additional 631,172 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of IDEX by 10.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,269,952 shares of the industrial products company's stock valued at $746,628,000 after purchasing an additional 306,008 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of IDEX by 316.9% in the third quarter. Ameriprise Financial Inc. now owns 368,849 shares of the industrial products company's stock valued at $76,667,000 after purchasing an additional 280,385 shares during the last quarter. 97.96% of the stock is currently owned by institutional investors and hedge funds.

IDEX Trading Down 0.3 %

NYSE:IEX traded down $0.73 during trading hours on Thursday, reaching $226.10. 248,282 shares of the company were exchanged, compared to its average volume of 378,192. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.89 and a quick ratio of 2.05. The firm has a market cap of $17.11 billion, a price-to-earnings ratio of 28.84, a PEG ratio of 2.29 and a beta of 0.97. IDEX Co. has a 52-week low of $183.76 and a 52-week high of $246.36. The stock has a 50 day simple moving average of $236.43 and a 200 day simple moving average of $215.88.

IDEX (NYSE:IEX - Get Free Report) last posted its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $1.83 earnings per share for the quarter, topping analysts' consensus estimates of $1.78 by $0.05. The company had revenue of $788.90 million for the quarter, compared to the consensus estimate of $767.96 million. IDEX had a net margin of 18.21% and a return on equity of 18.56%. IDEX's revenue was down 2.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.01 earnings per share. As a group, analysts predict that IDEX Co. will post 8.35 EPS for the current year.

Wall Street Analysts Forecast Growth

IEX has been the topic of several research reports. Oppenheimer increased their price target on shares of IDEX from $245.00 to $252.00 and gave the company an "outperform" rating in a research report on Thursday. StockNews.com upgraded shares of IDEX from a "hold" rating to a "buy" rating in a research report on Tuesday. Citigroup increased their price target on shares of IDEX from $254.00 to $277.00 and gave the company a "buy" rating in a research report on Monday, April 8th. Stifel Nicolaus upgraded shares of IDEX from a "hold" rating to a "buy" rating and increased their price target for the company from $215.00 to $265.00 in a research report on Thursday, February 8th. Finally, Royal Bank of Canada restated an "outperform" rating and set a $255.00 target price on shares of IDEX in a research report on Thursday, March 21st. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, IDEX currently has an average rating of "Moderate Buy" and a consensus target price of $238.78.

IDEX Company Profile

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.